Solid Novartis caught in perfect storm of currency headwinds
This article was originally published in Scrip
Executive Summary
Novartis has reported a solid set of financials for 2013, but the Swiss firm, which has a high Swiss cost base but reports in US dollars, was dragged down by currency effects.